Literature DB >> 23284074

The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.

Kyu-Hyang Cho1, Jun-Young Do, Jong-Won Park, Kyung-Woo Yoon, Yong-Lim Kim.   

Abstract

BACKGROUND: Several studies have reported benefits for human peritoneal mesothelial cell function of a neutral-pH dialysate low in glucose degradation products (GDPs). However, the effects of low-GDP solution on ultrafiltration (UF), transport of solutes, and control of body water remain elusive. We therefore investigated the effect of low-GDP solution on UF, solute transport, and control of body water.
METHODS: Among 79 new continuous ambulatory peritoneal dialysis (CAPD) patients, 60 completed a 12-month protocol (28 in a lactate-based high-GDP solution group, 32 in a lactate-based low-GDP solution group). Clinical indices--including 24-hour UF volume (UFV), 24-hour urine volume (UV), residual renal function, and dialysis adequacy--were measured at months 1, 6, and 12. At months 1, 6, and 12, UFV, glucose absorption, 4-hour dialysate-to-plasma (D/P) creatinine, and 1-hour D/P Na(+) were assessed during a modified 4.25% peritoneal equilibration test (PET). Body composition by bioelectric impedance analysis was measured at months 1 and 12 in 26 CAPD patients.
RESULTS: Daily UFV was lower in the low-GDP group. Despite similar solute transport and aquaporin function, the low-GDP group also showed lower UFV and higher glucose absorption during the PET. Factors associated with UFV during the PET were lactate-based high-GDP solution and 1-hour D/P Na(+). No differences in volume status and obesity at month 12 were observed, and improvements in hypervolemia were equal in both groups.
CONCLUSIONS: Compared with the high-GDP group, the low-GDP group had a lower UFV during a PET and a lower daily UFV during the first year after peritoneal dialysis initiation. Although the low-GDP group had a lower daily UFV, no difficulties in controlling edema were encountered.

Entities:  

Keywords:  Low-GDP solution; solute transport; ultrafiltration

Mesh:

Substances:

Year:  2013        PMID: 23284074      PMCID: PMC3707716          DOI: 10.3747/pdi.2011.00279

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  33 in total

1.  Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate/lactate formulation.

Authors:  D J Millar; C Holmes; D Faict; A Dawnay
Journal:  Adv Perit Dial       Date:  1998

Review 2.  Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis.

Authors:  S Mujais; K Nolph; R Gokal; P Blake; J Burkart; G Coles; Y Kawaguchi; H Kawanishi; S Korbet; R Krediet; B Lindholm; D Oreopoulos; B Rippe; R Selgas
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

3.  Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells.

Authors:  Sonja Mandl-Weber; Clemens D Cohen; Bettina Haslinger; Matthias Kretzler; Thomas Sitter
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

4.  Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?

Authors:  Martin Zeier; Vedat Schwenger; Reinhold Deppisch; Ulrike Haug; Kai Weigel; U Bahner; Christoph Wanner; H Schneider; Thomas Henle; Eberhard Ritz
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

5.  Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.

Authors:  L A Cooker; P Luneburg; C J Holmes; S Jones; N Topley
Journal:  Perit Dial Int       Date:  2001       Impact factor: 1.756

6.  Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.

Authors:  Naoki Washida; Shu Wakino; Yukio Tonozuka; Koichiro Homma; Hirobumi Tokuyama; Yoshikazu Hara; Kazuhiro Hasegawa; Hitoshi Minakuchi; Keiko Fujimura; Kohji Hosoya; Koichi Hayashi; Hiroshi Itoh
Journal:  Nephrol Dial Transplant       Date:  2011-03-04       Impact factor: 5.992

7.  Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function.

Authors:  Peter J Margetts; Martin Kolb; Tom Galt; Catherine M Hoff; Ty R Shockley; Jack Gauldie
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

8.  Effect of glucose degradation products on human peritoneal mesothelial cell function.

Authors:  Janusz Witowski; Katarzyna Korybalska; Justyna Wisniewska; Andrzej Breborowicz; Gerhard M Gahl; Ulrich Frei; Jutta Passlick-Deetjen; Achim Jörres
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

9.  Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis.

Authors:  Sophie Combet; Toshio Miyata; Pierre Moulin; Dominique Pouthier; Eric Goffin; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

10.  Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate.

Authors:  Roberto Pecoits-Filho; Maria Regina T Araújo; Bengt Lindholm; Peter Stenvinkel; Hugo Abensur; João Egídio Romão; Marcelo Marcondes; André H Freiria De Oliveira; Irene L Noronha
Journal:  Nephrol Dial Transplant       Date:  2002-08       Impact factor: 5.992

View more
  6 in total

Review 1.  Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.

Authors:  Seychelle Yohanna; Ali M A Alkatheeri; Scott K Brimble; Brendan McCormick; Arthur Iansavitchous; Peter G Blake; Arsh K Jain
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 8.237

Review 2.  Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.

Authors:  Eun-Young Seo; Sook Hee An; Jang-Hee Cho; Hae Sun Suh; Sun-Hee Park; Hyesun Gwak; Yong-Lim Kim; Hunjoo Ha
Journal:  Perit Dial Int       Date:  2014-09-02       Impact factor: 1.756

3.  Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts.

Authors:  J Haybrard; N Simon; C Danel; C Pinçon; C Barthélémy; F J Tessier; B Décaudin; E Boulanger; P Odou
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

Review 4.  Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease.

Authors:  Xin Liu; Chunsun Dai
Journal:  Kidney Dis (Basel)       Date:  2016-09-07

5.  Strategies for preserving residual renal function in peritoneal dialysis patients.

Authors:  Arkom Nongnuch; Montira Assanatham; Kwanpeemai Panorchan; Andrew Davenport
Journal:  Clin Kidney J       Date:  2015-01-13

6.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.